Javascript must be enabled to continue!
Changes and determinants of pneumococcal vaccine uptake in Ethiopia
View through CrossRef
Abstract
Background:
Pneumococcal pneumonia is one of the most common causes of severe pneumonia and pneumonia-related mortality globally. It is one of the top five causes of mortality and mortality in children under five in Ethiopia. Vaccinating children reduced the disease burden of pneumonia and death-related pneumococcal infection for both child and adult populations. Pneumococcal Pneumonia is one of the vaccine-preventable diseases.
Objective: To assess how pneumococcal vaccine uptake changes over time and to identify factors associated with uptake of the pneumococcal vaccine.
Data: This study was conducted based on secondary data obtained from the Ethiopian Demographic and Health Surveys (EDHS) conducted in 2016 and 2019, two nationally representative surveys. A total of 1929 and 1008 children of aged 12–23 months were included res from the 2016 and 2019 Demographic and Health Surveys respectively.
Method: The Percentage change in pneumococcal vaccine (PCV) coverage was used to quantify the degree of change over time. To identify the significant factors associated with the uptake of PCV vaccines, a multilevel ordinal logistic regression model was used. All statistical tests were run with a significance threshold of 5%.
Result:The percentage of children aged 12-23 months who received complete doses of PCV vaccination increased from 49.1% in 2016 to 59.8% in 2019 with a significant 21.8% increase [95% CI: 9.8-35.2]. Children in rural areas are 69% less likely to receive more doses of PCV vaccinations than those who live in urban areas (AOR=0.307, 95% CI: 0.127 - 0.742). Second-or higher-order births are associated with higher uptake of doses of PCV vaccinations (AOR=2.519, 95% CI: 1.143-5.548]). Compared to children born at home, children born in health facilities were 2.35 times more likely to receive greater doses of the PCV vaccination (AOR=2.350, 95% CI: 1.132-4.882). Children born from the women who received more ANC visits were significantly more likely to receive complete PCV coverage.
Conclusion: We observed a significant increase in the uptake of PCV vaccines across the two survey years even though Ethiopia is still far away from achieving national immunization goals. Our results also show that place of residence, birth order, place of delivery, ANC visits, and region were significantly associated with pneumococcal vaccine uptake.
Research Square Platform LLC
Title: Changes and determinants of pneumococcal vaccine uptake in Ethiopia
Description:
Abstract
Background:
Pneumococcal pneumonia is one of the most common causes of severe pneumonia and pneumonia-related mortality globally.
It is one of the top five causes of mortality and mortality in children under five in Ethiopia.
Vaccinating children reduced the disease burden of pneumonia and death-related pneumococcal infection for both child and adult populations.
Pneumococcal Pneumonia is one of the vaccine-preventable diseases.
Objective: To assess how pneumococcal vaccine uptake changes over time and to identify factors associated with uptake of the pneumococcal vaccine.
Data: This study was conducted based on secondary data obtained from the Ethiopian Demographic and Health Surveys (EDHS) conducted in 2016 and 2019, two nationally representative surveys.
A total of 1929 and 1008 children of aged 12–23 months were included res from the 2016 and 2019 Demographic and Health Surveys respectively.
Method: The Percentage change in pneumococcal vaccine (PCV) coverage was used to quantify the degree of change over time.
To identify the significant factors associated with the uptake of PCV vaccines, a multilevel ordinal logistic regression model was used.
All statistical tests were run with a significance threshold of 5%.
Result:The percentage of children aged 12-23 months who received complete doses of PCV vaccination increased from 49.
1% in 2016 to 59.
8% in 2019 with a significant 21.
8% increase [95% CI: 9.
8-35.
2].
Children in rural areas are 69% less likely to receive more doses of PCV vaccinations than those who live in urban areas (AOR=0.
307, 95% CI: 0.
127 - 0.
742).
Second-or higher-order births are associated with higher uptake of doses of PCV vaccinations (AOR=2.
519, 95% CI: 1.
143-5.
548]).
Compared to children born at home, children born in health facilities were 2.
35 times more likely to receive greater doses of the PCV vaccination (AOR=2.
350, 95% CI: 1.
132-4.
882).
Children born from the women who received more ANC visits were significantly more likely to receive complete PCV coverage.
Conclusion: We observed a significant increase in the uptake of PCV vaccines across the two survey years even though Ethiopia is still far away from achieving national immunization goals.
Our results also show that place of residence, birth order, place of delivery, ANC visits, and region were significantly associated with pneumococcal vaccine uptake.
Related Results
Immunogenicity of Minhai 13-valent pneumococcal polysaccharide conjugate vaccine in experimental mice
Immunogenicity of Minhai 13-valent pneumococcal polysaccharide conjugate vaccine in experimental mice
Diseases caused by pneumococci are a global public health problem. The widespread use of antibiotics has led to a sharp increase in the drug resistance of pneumococci, making resea...
Prevnar 13, the New 13-Valent Pneumococcal Conjugate Vaccine
Prevnar 13, the New 13-Valent Pneumococcal Conjugate Vaccine
Objective: To review the immurtogenicity, efficacy, and safety of the 13-valent pneumococcal conjugate vaccine (PCV13) for use in pediatric patients. Data Sources: A MEDLINE search...
Effects of Pneumococcal Vaccination in Children Under Five Years of Age in the Democratic Republic of Congo: A Systematic Review
Effects of Pneumococcal Vaccination in Children Under Five Years of Age in the Democratic Republic of Congo: A Systematic Review
Background: In the Democratic Republic of Congo (DRC), the 13-valent pneumococcal conjugate vaccine (PCV13) was introduced in 2011 through a three-dose schedule, targeting infants ...
Attitudes towards COVID-19 vaccination, vaccine hesitancy and intention to take the vaccine
Attitudes towards COVID-19 vaccination, vaccine hesitancy and intention to take the vaccine
Background: The pandemic is at a paradoxical stage, with vaccine roll out initiated but a significantly elevated level of infection and death. Hope for recovery lies in high equita...
Pneumococcal Vaccine Response After Exposure to Parasites in Utero, in Infancy, or Mid-Childhood
Pneumococcal Vaccine Response After Exposure to Parasites in Utero, in Infancy, or Mid-Childhood
BACKGROUND AND OBJECTIVE:Streptococcus pneumoniae is a leading cause of mortality before age 5, but few studies examine details of childhood response to pneumococcal vaccine in les...
Lung uptake on I-131 therapy and short-term outcome in patients with lung metastasis from differentiated thyroid cancer
Lung uptake on I-131 therapy and short-term outcome in patients with lung metastasis from differentiated thyroid cancer
Abstract
Objective
It is sometimes difficult to assess I-131 lung uptake at the initial I-131 therapy because of strong artifacts from I-131 upta...
Evaluating clinical effectiveness and safety of pneumococcal immunization of infants
Evaluating clinical effectiveness and safety of pneumococcal immunization of infants
According to WHO, pneumococcal infection (PI) is considered one of the most dangerous of all vaccine-preventable diseases and, before vaccination, led to the death of up to 1.6 mil...
COVID-19 vaccine hesitancy among adults in Hawassa City Administration, Sidama Region, Ethiopia: A community-based study
COVID-19 vaccine hesitancy among adults in Hawassa City Administration, Sidama Region, Ethiopia: A community-based study
ObjectiveThe COVID-19 vaccine is one of the key measures to control the disease. However, some people are hesitant to take the vaccine. The objective of this study was to assess CO...

